NASDAQ · Analyst Forecast

Cumberland Pharmaceuticals Inc. (CPIX) Stock Forecast & Price Target

$5.80 NASDAQ: CPIX Market Cap $86.90M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Cumberland Pharmaceuticals Inc. (CPIX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Cumberland Pharmaceuticals Inc., analysts forecast revenue rising from $38.23M in 2026 to $44.85M in 2031; the average estimate for 2031 earnings per share is −$0.23; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2026$38.23M$38.23M$38.23M1
2027$38.23M$38.23M$38.23M1
2028$45.20M$45.20M$45.20M1
2029$36.96M$36.96M$36.96M1
2030$40.97M$40.97M$40.97M1
2031$44.85M$44.85M$44.85M1

Earnings per share forecast

YearLowAverageHighAnalysts
2026−$0.55−$0.55−$0.551
2027−$0.55−$0.55−$0.551
2028−$0.31−$0.31−$0.311
2029−$0.22−$0.22−$0.221
2030−$0.03−$0.03−$0.031
2031−$0.23−$0.23−$0.231

Cumberland Pharmaceuticals Inc. (CPIX) forecast — frequently asked questions

What are analysts forecasting for Cumberland Pharmaceuticals Inc.'s earnings?

The average analyst estimate for Cumberland Pharmaceuticals Inc. (CPIX) earnings per share in 2031 is -0.23, with individual estimates between -0.23 and -0.23.

How much revenue is Cumberland Pharmaceuticals Inc. expected to make?

Analysts forecast Cumberland Pharmaceuticals Inc. (CPIX) revenue of $44.85M in 2031, based on 1 published estimates.

How many analysts cover CPIX?

1 analyst contribute estimates for Cumberland Pharmaceuticals Inc. (CPIX). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - Specialty & Generic stocks

TEVA forecastZTS forecastVTRS forecastELAN forecastRDY forecastALKS forecastAMRX forecastLNTH forecastSUPN forecastBHC forecastAll Drug Manufacturers - Specialty & Generic stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.